|Grant Affiliation:||Pantaleo: Poxvirus-Based Vaccine Development|
|Strategy:||Combo: DNA, protein & vector vaccines|
|Study Type:||Pre-Clinical NHP|
|Study Start Date:||2010-11-16|
|Study Made Public:||2013-08-16|
Evaluate and compare immunogenicity and safety of the highly attenuated replication competent NYVAC-C-KC vs. replication incompetent NYVAC-C in the vaccination combination with DNA and protein
CAVD 259 (AUP444/CAVIMC-033) is a non-human primate study comparing 5 different prime/boost regimens of NYVAC-C-KC or NYVAC-C in combination with DNA-C, protein, and MF59.
Sign in to see full information about this study and to download study data.